Markets · 1 sources covering this

Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.

The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — much like a GLP-1.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

MarketWatchCenter·1h ago
Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.
The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — much like a GLP-1.
Read at MarketWatch →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/e3b8b9d6b5c815cf162764c53143f1266be6e6e1"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Adding Lilly&#x2019;s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects."></iframe>

Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.

How 1 sources are covering this

Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.

More from Markets

‘We lived within our means’: I earned $30,000 as a pastor and still retired comfortably. Why don’t you tell people that?

Citi tells investors it’s time to sell Moderna after 600%-plus stock gains

Amex's New AI Agent for Expenses

Brightline Offers 4.75% Equity Stake to Lure Hedge Fund Holdouts

Reader

Trust & legal

Across the network

How 1 sources are covering this

Adding Lilly&#x2019;s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.

More from Markets

&#x2018;We lived within our means&#x2019;: I earned $30,000 as a pastor and still retired comfortably. Why don&#x2019;t you tell people that?

Citi tells investors it&#x2019;s time to sell Moderna after 600%-plus stock gains

Amex's New AI Agent for Expenses

Brightline Offers 4.75% Equity Stake to Lure Hedge Fund Holdouts

Reader

Trust & legal

Across the network

Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.

‘We lived within our means’: I earned $30,000 as a pastor and still retired comfortably. Why don’t you tell people that?

Citi tells investors it’s time to sell Moderna after 600%-plus stock gains